PRIMECAP Management Co. Holds 14.47M Shares of FibroGen Stock

TL;DR

**PRIMECAP still owns a huge chunk of FibroGen, signaling continued institutional interest.**

AI Summary

PRIMECAP Management Company, a major institutional investor, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in FibroGen, Inc. As of December 31, 2023, PRIMECAP beneficially owned 14,471,928 shares of FibroGen's common stock, representing a significant stake. This filing is important for investors as it updates the public on a large institutional holder's position, indicating their continued confidence or changes in their investment strategy in FibroGen.

Why It Matters

This filing shows that a large institutional investor, PRIMECAP Management Company, maintains a substantial position in FibroGen, which can influence stock stability and investor sentiment.

Risk Assessment

Risk Level: low — The filing indicates a stable, large institutional holding, which generally reduces volatility and provides a degree of confidence.

Analyst Insight

A smart investor would note PRIMECAP's continued substantial holding as a potential sign of long-term institutional confidence in FibroGen, but should also research any changes in the percentage of ownership from previous filings to understand if their conviction is increasing or decreasing.

Key Numbers

• 14,471,928 — Aggregate Shares Beneficially Owned (This is the total number of FibroGen shares PRIMECAP Management Company holds, indicating their significant investment.)
• 13,774,128 — Sole Voting Power Shares (This shows the number of shares PRIMECAP can vote on its own, reflecting its direct influence on company decisions.)

Key Players & Entities

• PRIMECAP Management Company (company) — the reporting person and institutional investor
• FibroGen, Inc. (company) — the subject company whose securities are being reported
• 14,471,928 (dollar_amount) — aggregate amount of shares beneficially owned by PRIMECAP
• December 31, 2023 (date) — the date of the event requiring the filing
• February 12, 2024 (date) — the filing date of the SC 13G/A

Forward-Looking Statements

• PRIMECAP Management Company will maintain a significant stake in FibroGen, Inc. throughout 2024. (PRIMECAP Management Company) — medium confidence, target: December 31, 2024

FAQ

Filing Documents

• fgena5_21224.htm (SC 13G/A) — 26KB
• 0001085146-24-001079.txt ( ) — 27KB

(a)

ITEM 1(a). NAME OF ISSUER: FibroGen, Inc.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 409 Illinois Street, San Francisco, CA 94158

(a)

ITEM 2(a). NAME OF PERSON FILING: PRIMECAP Management Company

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 177 E. Colorado Blvd., 11th Floor, Pasadena, CA 91105

(c)

ITEM 2(c). CITIZENSHIP: U.S.A.

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: COM

(e)

ITEM 2(e). CUSIP NUMBER: 31572Q808 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 14,471,928 (b) Percent of class: 14.72% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: 13,774,128 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or direct the disposition of: 14,471,928 (iv) shared power to dispose or to direct the disposition of: 0 ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of secur

View Full Filing

View this SC 13G/A filing on SEC EDGAR